Orbis Medicines
Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Orbis Medicines is a business in medical, pharmaceutical, therapeutics based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2021.
As a business in medical, pharmaceutical, therapeutics, Orbis Medicines is listed here with the public details available about it.
The business is associated with European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Seed stage of development.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $26M in funding.
| Sector | Medical, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $26,000,000 |
Website: www.orbismedicines.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account